跳至主要内容
临床试验/NCT04800770
NCT04800770Unknown不适用

Phosphate Levels of COVID-19 Patients and Mortality

Ankara City Hospital Bilkent1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2021年3月3日最近更新:
适应症

试验速览

阶段
不适用
入组人数
160
试验地点
1
主要终点
mortality

研究概览

简要总结

The investigators aimed to investigate the relationship between phosphate level and mortality using the 4C Mortality Score in COVID-19 patients who were followed up in the intensive care unit.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • Participants hospitalized in the intensive care unit diagnosed with COVID-19 will incluse in the study

排除标准

  • there is no exclusion criteria

结局指标

主要结局

mortality

时间窗: 28 days

mortality percentage of patients in 28 days

4C mortality score

时间窗: 6 months

4C Mortality Scores of the patients will be calculated, according to age, gender, number of comorbidities, respiratory rate, SpO2, GCS, urea, and CRP parameters

serum phosphate levels

时间窗: 6 months

mg/dl

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

ismail aytaç

medical doctor

Ankara City Hospital Bilkent

研究点 (1)

Loading locations...

相似试验